Beyond Measure: Expert Discussion on the Health Equity Index [Pharmacist]

Beyond Measure: Expert Discussion on the Health Equity Index [Pharmacist]

This course will explore the fundamental concepts of health equity and social determinants of health (SDoH) through an engaging discussion with leading professionals. Content will provide comprehensive insights into the newly introduced Health Equity Index (HEI) by the Center of Medicare and Medicaid Services (CMS), equipping pharmacists to identify and address health equity issues within community pharmacies. Learners will explore actionable strategies to mitigate disparities, enhance access, and improve outcomes, fostering a proactive approach to promoting health equity in this dynamic pharmacy education experience.

Upon successful completion of this knowledge-based CPE course, pharmacists should be able to:
1. Define health equity and social determinants of health (SDoH).
2. Recognize the impact of SDoH on health outcomes, patient care, and healthcare costs.
3. Explain the key elements of the new Health Equity Index (HEI) by the Center of Medicare and Medicaid Services (CMS).
4. Identify the role of community pharmacies in addressing health equity issues within the context of the upcoming HEI.
5. Describe strategies that address disparities in healthcare access, outcomes, and quality within a pharmacy setting.

John A. Galdo, PharmD, MBA, BCPS, BCGP
Seguridad d/b/a CPESN Health Equity

Sanjay Patel, BS Pharmacy
Director of Pharmacy
Haller’s Pharmacy and Medical Supply

Michelle Garvin, CPhT, CHW
Owner, Vice President
Wester Drugs, Inc

Roger Paganelli, RPh
Co-Owner and Pharmacist
Mt. Carmel Pharmacy

Jennifer Baker, Pharm.D.
Pharmacy Manager and Partner/Owner
Sikeston MediCenter Pharmacy

Jude Ohaya, PharmD
Pharmacist In Charge
Trustee Drugs Inc

John A. Galdo reports he is CEO of Seguridad and his spouse works for Eli Lilly and was an employee of Prime Therapeutics. All relevant financial relationships have been mitigated.  

Sanjay Patel, Michelle Garvin, Roger Paganelli, Jennifer Baker, and Jude Ohaya have no relevant financial relationships with ineligible companies to disclose.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: March 13, 2024
Planned Expiration Date: March 13, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-24-047-H04-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator




ACPE Topic

04 Pharmacy Administration





Release Date




ACPE Number


This course is in our subscription.